CRP and chronic kidney disease: We conclude; superior platelet anti-aggregatory effect, better lowering of C-Reactive protein and safety on renal function of Clopidogrel over Aspirin and at an affordable cost makes clopidogrel an efficacious but safer alternative to aspirin in patients of Chronic Kidney Disease who require prophylaxis of Cardio Vascular Disease.